An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT02576509 · COMPLETED
Trial details
- NCT number
- NCT02576509
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-07
- Primary completion
- 2019-05-30
- Enrollment
- 743
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.